Search results

Page results

• History making decision announced for Thalassaemia patients!

  Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over. 

• Lower Gastrointestinal suspected cancer pathway

  This page is for patients who have been referred on a suspected cancer pathway.

• UCL, UCLH and Formula One develop life-saving breathing aids for the NHS

  A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• High blood pressure and its drug treatment unlikely to increase entry of COVID-19 virus into cells

  Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.

• COVID-19 booster vaccination clinics

  At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.

• NEW: Helpful videos about managing common cancer treatment side effects

  Short videos on managing cancer pain, cancer-related fatigue and improving sleep

• Getting Ready for Transition (GReaT) to secondary school

  Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 29 January 2025.

• Feeling sick - what you can do (Easy read)

  This page offers advice to patients who are feeling sick.

• Cancer immunotherapy treatment

  This page is for cancer patients receiving immunotherapy treatment.